SUMMARY
Mephentermine, a sympathomimetic amine having -and -adrenergic agonist actions, is commonly used in India as a vasopressor for prevention and treatment of hypotension following spinal anaesthesia. However, in most parts of the world, until recently ephedrine has been the drug most used for this purpose for many decades. According to a survey of practice published in 2001, ephedrine was the sole vasoconstrictor selected by 95.2% consultant obstetric anaesthetists in the U.K. 1 . The doses of ephedrine required for prevention and treatment of hypotension are well described in the literature [2] [3] [4] [5] . However, there is a paucity of information on the use of mephentermine. The various dosage regimens mentioned for treatment of hypotension using mephentermine are 30 mg intravenously (IV) 6 , 30 to 45 mg IV 7 and 6 mg IV boluses 8 . In our earlier study 9 , we have shown that treatment of hypotension in pregnant females receiving subarachnoid block for lower segment caesarean section. In that study, we used both the vasopressors in similar doses, assuming the two to be equipotent. Other investigators have also compared similar doses of ephedrine and mephentermine for treatment of hypotension 8 . However, the literature does not mention a prophylactic IV dose of mephentermine and there are no studies comparing the minimum effective dose of this drug with that of ephedrine for prevention of post-spinal hypotension. Hence, the present study was carried out in an effort to determine the minimum effective dose (ED 50 ) of mephentermine and to compare its potency with that of ephedrine for prevention of hypotension in parturients undergoing caesarean section under spinal anaesthesia.
MATERIALS AND METHODS
Following institutional ethics committee approval, this prospective, randomised, double-blind study was carried out by sequential allocation of doses of each vasopressor.
After obtaining written informed consent, the study was conducted in 46 ASA I or II females aged 18 years or more and having term, uncomplicated, singleton pregnancy who underwent elective caesarean section under subarachnoid block.
Patients suffering from diabetes, pregnancy-induced hypertension, cardiovascular disease, cerebrovascular diseases, autonomic neuropathy, spinal deformities, other neurological diseases, infections in the lumbar area, coagulation abnormalities, hypovolaemia due to any cause and systolic blood pressure (SBP) less than 100 mmHg were excluded from the study.
All patients were anaesthetised using subarachnoid block with bupivacaine and all received an infusion of vasopressor to prevent hypotension. Height and weight of the patients were measured during a pre-anaesthetic visit and participants were asked to fast overnight. All received ranitidine 150 mg orally the night before and ranitidine 50 mg and metoclopramide 10 mg IV one hour before surgery. In the operating theatre, baseline values for maternal SBP and heart rate (HR) were recorded as the average of three readings, with the patients lying supine with a standard sized wedge under the right buttock. An IV line was established and Ringer lactate solution 10 ml/kg administered over a period of 10 to infusion rate was reduced to 4 ml/kg/h. Lumbar puncture was performed by midline approach with the patient in the left lateral position, using a 25 gauge Quincke spinal needle inserted at the L 2 -L 3 or L 3 -L 4 vertebral interspace. A volume of 2.2 ml of hyperbaric 0.5% bupivacaine was injected in patients of height greater than 150 cm, as is the routine practice in our institution. The volume of bupivacaine was reduced to 2 ml for those 150 cm or less. The patient was then immediately turned supine, a wedge placed under her right buttock and the prophylactic infusion of vasopressor was started. Oxygen was administered by clear facemask throughout the procedure. The upper level of sensory block was assessed in midline by pin prick using a sterile 26 gauge needle. The aim was to achieve a minimum sensory block of T6. Any patient whose block failed to reach this level was withdrawn from the study and that dose of vasopressor was repeated for the next patient. Monitoring included continuous electrocardiogram, HR, non-invasive blood pressure and pulse oximetry. Heart rate and SBP were recorded at the time of spinal drug injection and then every two minutes until delivery of the baby.
The patients were randomly allocated to the 'Ephedrine group' or 'Mephentermine group' by in either group received a dose of 50 mg. The dose of vasopressor was diluted to 20 ml with normal saline and the infusion was started at a rate of 40 ml/h using an Emco Infusor 850 syringe infusion pump (Emco Meditek Pvt Ltd, Mumbai, India). The initial dose and the dose interval were chosen based on previous literature about ephedrine 10 , making the assumption that the two vasopressors are equipotent.
of <100 mmHg, which ever was higher. If hypotension occurred during the study period, the particular dose of vasopressor was considered as ineffective and the next successive patient received a dose increased by 5 mg in that group. On the other hand, if hypotension was prevented, this dose was deemed effective and the dose for the next patient was decreased by 5 mg. The observer assessing the of vasopressor infusion. Hypotension was treated with bolus doses of ephedrine 5 mg IV, repeated as required, irrespective of the group. Whenever SBP exceeded the baseline value, the infusion rate was decreased in steps of 4 ml/h. Thus, the aim was to maintain SBP between hypotension value and baseline value. The study continued until the time of delivery or 30 minutes, whichever was earlier.
Any maternal complications during the study period were noted and appropriately managed.
Statistical analysis
Statistical analysis was performed using Statistical Package for SPSS version 13.0. Student's unpaired t-test and Mann Whitney U-test were used to compare demographic and other characteristics in the two groups. The data for these characteristics are presented as mean (SD) or median (range).
It was decided to base the sample size on previous literature of the up-down method of Dixon, according to which at least six independent pairs of patients with no hypotension/hypotension (response/no response pairs) should provide reliable estimates of minimum effective dose of vasopressor (ED 50 ) 11 . This method was used to calculate the minimum effective group. However, in the mephentermine group, the unanticipated pattern of response made it impossible
RESULTS
The two groups were comparable with respect to age, weight, height, parity, baseline HR, baseline SBP and subarachnoid block to delivery interval ( Table 1) .
The sequences of dose against patient for ephedrine and mephentermine are shown in Figures 1 and 2 respectively. In the ephedrine group, of at least six independent response/no response pairs for up-down analysis (Figure 1 ). On the other mephentermine group. As evident from Figure 2 , following an initial uninterrupted string of successes in this group, a failure occurred at the dose of was formed. This was again followed by another string of successes until the dose of 10 mg resulted in the next failure and hence the second response/ no response pair. However, there were consecutive successes after this and the 14th patient received a dose of 5 mg, which was also successful in preventing hypotension. The dose could not be reduced any further since the dose interval itself was 5 mg and hence this was the minimum dose possible in this group. Therefore, the procedure of sequential allocation of doses had to be abandoned and it was decided to manage 10 cases with the same dose of 5 mg, irrespective of the outcome. Of these 10 patients, hypotension occurred in only two patients, therefore 5 mg was effective in 80%. Twenty-four patients were studied in this group, with one excluded because the height of block failed to reach T6. The sequences for the 23 patients are shown in Figure 2 .
The ED 50 of ephedrine was 25.0 mg (95% CI 15.5 to 40.4 mg), as calculated by the formula of Dixon and Massey
12
. The ED 50 of mephentermine could not be calculated; however, it appears to be less than 5 mg as the dose of 5 mg of mephentermine was successful in preventing hypotension in 80% of cases.
In one patient in each group, HR increased to more than 130 beats/minute during the study period. Four patients in mephentermine group had one or more readings of heart rate below 60 beats/minute, but none of these patients required treatment with vagolytic agents.
The rate of infusion of vasopressor needed to be reduced in 11 patients in the mephentermine group due to SBP overshooting the baseline value, whereas it was reduced in only three patients in the ephedrine group. In these 11 patients in the mephentermine group, the peak SBP values were 10 to 32 mmHg higher than the respective baseline SBP values. The rate of mephentermine infusion was reduced from 40 ml/h to 36 ml/h in three patients, 32 ml/h in one, 28 ml/h in two, 24 ml/h in one, 20 ml/h in three and to 16 ml/h in one patient. On the other hand, three patients in the ephedrine group showed a peak rise in SBP of 11 to 31 mmHg above the respective baseline SBP values. The rate of ephedrine infusion was decreased to 28 ml/h in two patients and 16 ml/h in one patient.
One patient in the ephedrine group complained of nausea and chest pain. This patient had hypotension and required two bolus doses of ephedrine 5 mg. Shivering occurred in one patient in the mephentermine group. 
DISCUSSION
Mephentermine has been in use in India to treat and prevent hypotension for a number of decades. However, there is a paucity of literature regarding the dose requirements or its relative potency compared with other vasopressors.
In 1978, Lauckner et al used mephentermine 30 mg IV to treat hypotension in pregnant females 6 , whereas the drug information by Wyeth ® , India gives a dose of 30 to 45 mg intramuscularly for prevention and 30 to 45 mg IV for treatment of post-spinal hypotension 7 . Other doses used are 6 mg boluses 8 and a 5 mg bolus followed by an infusion 9 . In our institution, the routine bolus dose used for treatment of post-spinal hypotension is 3 to 5 mg, repeated as required. However, an IV dose of mephentermine for prophylaxis of hypotension is not mentioned in literature.
The mechanism of action of ephedrine and mephentermine is similar. Both drugs have -as well as -adrenergic agonist actions and act both directly and indirectly at adrenergic nerve endings. Effect on -receptors is more prominent than that on receptors. Despite similar actions, the trials early years, mephentermine was reported to be as potent as ephedrine with respect to its effect on total vascular and venous resistance in the perfused foreleg of the dog 13 , whereas it was found to be more potent than other agents including ephedrine for restoring the contractility of depressed and hypodynamic isolated frog heart 14 . Only a few clinical studies have compared these two vasopressors. Sahu et al 8 compared 6 mg bolus doses of ephedrine and mephentermine following onset of hypotension and observed similar requirements for both drugs for maintenance of arterial pressure during caesarean section. In our previous study, we also assumed the two vasopressors to be equipotent and used similar infusion rates in both groups to treat hypotension 9 .
for treatment of hypotension. However, the potency ratio of mephentermine and ephedrine for prevention of hypotension has never been studied in human beings. Considering the above facts, the present study was designed to determine the ED 50 of mephentermine and to compare its potency with that of ephedrine for prevention of hypotension in term obstetric patients undergoing caesarean section under subarachnoid block.
The ED 50 of ephedrine found by the sequential allocation method in this study was 25.0 mg (95% CI 15.5 to 40.4 mg). This is much less than the value reported by Saravanan et al who found it to be 43.3 mg (95% CI 39.2 to 47.3 mg) using a similar technique of sequential allocation 10 . The lower requirement of ephedrine in our study could be a result of differences in the methodology. Our target sensory level after subarachnoid block was T6 in contrast to T5 used by Saravanan et al. Moreover, we preloaded our patients with Ringer lactate 10 ml/kg prior to administration of subarachnoid block, whereas Saravanan and co-workers commenced a normal saline 500 ml infusion and then started the regional technique. Fluid although its importance has been challenged 15 . Fluid loading prior to obstetric spinal anaesthesia remains a widespread practice 1 . We chose to administer a volume of 10 ml/kg as volumes greater than this 20 and 30 ml/kg of crystalloid preload and found no or ephedrine requirement with the higher volumes 16 . In the mephentermine group we achieved an unanticipated success with the lowest possible dose of making six pairs of response/no response. The calculation of ED 50 for this group using Dixon's method was also not possible. Therefore, 10 cases were conducted with this minimum dose and the response (no hypotension) was seen in eight out of 10 cases, indicating that the ED 50 of mephentermine is likely to be less than 5 mg as an infusion given over 30 minutes.
We based the dose interval of ephedrine, i.e. a 5 mg increment or decrement in total dose for each patient, depending on the presence or absence of hypotension respectively in the previous patient, on earlier literature 10 . A similar dose interval was adopted for mephentermine since both drugs were assumed to be equipotent. However, based on the results of this study, wherein mephentermine appears to be more potent than ephedrine, we consider that prophylaxis with mephentermine needs to be investigated using a lower starting dose and smaller dose intervals.
Besides difference in potency, another explanation for the apparently lower requirements of mephentermine compared to ephedrine is the difference in their half-lives. The half-life of ephedrine is three to six hours 17, 18 , whereas that of mephentermine is 17 to 18 hours 19 . Although the duration of the infusion was only eight to 24 minutes and seven to 30 minutes in the ephedrine and longer half-life of mephentermine could be a factor in reducing its dose requirement.
In conclusion, the minimum effective dose of mephentermine appeared much less than that of ephedrine for the prevention of hypotension in parturients undergoing caesarean section under spinal anaesthesia. However, further studies are ratio for these vasopressor drugs.
